Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2023-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$59.8m reported value +35.0% vs Q4 2022
24positions
78.6%in top 10
6 new 6 added 0 reduced 3 sold out vs Q4 2022

Options: 2 call positions ($5.1m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q1 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 2,067,160 $20.5m34.32% 34.32% AddedShares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 2.1m +119.1k +119,070 6.1%
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 450,422 $6.2m10.29% 10.29% UnchangedShares held: Q3 2022 900.8k, Q4 2022 450.4k, Q1 2023 450.4k
3 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 200,000 $4.0m6.72% 6.72% AddedShares held: Q3 2022 0, Q4 2022 95.4k, Q1 2023 200.0k +104.6k +104,609 109.7%
4 VANECK ETF TRUST GOLD MINERS ETF GDX GDX 91,850 $3.0m4.97% 4.97% UnchangedShares held: Q3 2022 0, Q4 2022 91.8k, Q1 2023 91.8k
5 ENTERA BIO LTD SHS ENTX ENTX 2,484,275 $2.9m4.82% 4.82% UnchangedShares held: Q3 2022 2.5m, Q4 2022 2.5m, Q1 2023 2.5m
6 APPLIED THERAPEUTICS INC COM APLT APLT 3,450,000 $2.8m4.68% 4.68% AddedShares held: Q3 2022 1.1m, Q4 2022 2.5m, Q1 2023 3.5m +1.0m +1,000,000 40.8%
7 GLOBAL X FDS GLOBAL X SILVER SIL SIL 89,700 $2.8m4.61% 4.61% UnchangedShares held: Q3 2022 0, Q4 2022 89.7k, Q1 2023 89.7k
8 VANECK ETF TRUST JUNIOR GOLD MINE GDXJ GDXJ 53,150 $2.1m3.51% 3.51% UnchangedShares held: Q3 2022 0, Q4 2022 53.1k, Q1 2023 53.1k
9 OCULAR THERAPEUTIX INC COM OCUL OCUL 200,000 $1.5m2.51% 2.51% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 200.0k
10 OSISKO GOLD ROYALTIES LTD COM COM 400,000 $1.3m2.13% 2.13% AddedShares held: Q3 2022 235.0k, Q4 2022 235.0k, Q1 2023 400.0k +165.0k +165,000 70.2%
11 THERMO FISHER SCIENTIFIC INC COM TMO TMO 2,100 $1.2m2.03% 2.03% UnchangedShares held: Q3 2022 2.1k, Q4 2022 2.1k, Q1 2023 2.1k
12 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.2m2.01% 2.01% UnchangedShares held: Q3 2022 13.0k, Q4 2022 13.0k, Q1 2023 13.0k
13 VISA INC COM CL A V V 4,850 $1.1m1.83% 1.83% UnchangedShares held: Q3 2022 4.8k, Q4 2022 4.8k, Q1 2023 4.8k
14 CVS HEALTH CORP COM CVS CVS 14,500 $1.1m1.80% 1.80% UnchangedShares held: Q3 2022 14.5k, Q4 2022 14.5k, Q1 2023 14.5k
15 SILVERCREST METALS INC COM SIL SIL 170,000 $1.0m1.75% 1.75% NewShares held: Q3 2022 100.0k, Q4 2022 0, Q1 2023 170.0k
16 OMEGA THERAPEUTICS INC COMMON STOCK COMMON STOCK 173,010 $1.0m1.74% 1.74% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 173.0k
17 SEABRIDGE GOLD INC COM COM 80,000 $1.0m1.73% 1.73% AddedShares held: Q3 2022 41.0k, Q4 2022 41.0k, Q1 2023 80.0k +39.0k +39,000 95.1%
18 FRANCO NEV CORP COM FNV FNV 7,000 $1.0m1.71% 1.71% NewShares held: Q3 2022 4.9k, Q4 2022 0, Q1 2023 7.0k
19 ALTRIA GROUP INC COM MO MO 22,700 $1.0m1.69% 1.69% UnchangedShares held: Q3 2022 22.7k, Q4 2022 22.7k, Q1 2023 22.7k
20 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $999.6k1.67% 1.67% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.2k
21 Orgenesis, Inc. COM COM 634,738 $749.0k1.25% 1.25% UnchangedShares held: Q3 2022 1.3m, Q4 2022 634.7k, Q1 2023 634.7k
22 ALTIMMUNE INC COM NEW ALT ALT 173,864 $733.7k1.23% 1.23% UnchangedShares held: Q3 2022 173.9k, Q4 2022 173.9k, Q1 2023 173.9k
23 OPUS GENETICS INC COM IRD IRD 100,000 $375.0k0.63% 0.63% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 100.0k
24 HOOKIPA PHARMA INC COM COM 300,000 $220.8k0.37% 0.37% AddedShares held: Q3 2022 0, Q4 2022 50.0k, Q1 2023 300.0k +250.0k +250,000 500.0%

Sold out since Q4 2022

SecurityTickerShares held beforeValue then
AVADEL PHARMACEUTICALS PLC 150,000 $1.1m150.0k shares
BLACKSTONE GROUP L P BX BX 10,000 $741.9k10.0k shares
Anavex Life Sciences Corp 10,681 $98.9k10.7k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
AVADEL PHARMACEUTICALS PLC Call Call 500,000 $4.6m500.0k shares New
OCULAR THERAPEUTIX INC OCUL · Call OCULCall 95,800 $504.9k95.8k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08